Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports
One of the most powerful weapons against COVID-19 is vaccines. After the worldwide spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also in children and adolescents aged 12-18. Since then, alarming reports of cases of myocarditis and/or pericarditis have been not...
Saved in:
Main Authors: | Alessandra Piras (Author), Giada Melis (Author), Lucia Cugusi (Author), Pier Paolo Bassareo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myopericarditis
by: Richard Stair
Published: (2010) -
Clinical Case: Tuberculous Myopericarditis in the Cardiology Practice
by: A. I. Skripka, et al.
Published: (2018) -
Acute Myopericarditis Mimicking Acute Myocardial Infarction
by: Seval İzdeş, et al.
Published: (2011) -
Discovery of second generation heat shock protein 110 (HSP110) inhibitors for potential treatment of colorectal cancer
by: Li Xu, et al.
Published: (2023) -
A Unique Presentation of Bacterial Group G Streptococcus Myopericarditis
by: Sacide S. Ozgur MD, et al.
Published: (2024)